featured
Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ophthalmology Retina
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Final Outcomes from the Randomized RECOVERY Trial of Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy
Ophthalmol Retina 2022 Jul 01;6(7)557-566, CC Wykoff, MG Nittala, C Villanueva Boone, HJ Yu, W Fan, SB Velaga, JP Ehlers, MS Ip, SR SaddaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.